Advertisement
Screener

SUCAMPO PHARMACEUTICALS, INC. Revenue

SUCAMPO PHARMACEUTICALS, INC. Revenue

SUCAMPO PHARMACEUTICALS, INC. reported Revenue of $61.27 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.

Discontinued › Income Statement

us-gaap:Revenues · last filed 2017-11-01

  • SUCAMPO PHARMACEUTICALS, INC. revenues for the quarter ending 2017-09-30 was $61.27M, a 5.86% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for the quarter ending 2017-06-30 was $59.90M, a 15.29% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for the quarter ending 2017-03-31 was $56.28M, a 19.22% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for the quarter ending 2016-12-31 was $73.02M, a 31.89% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for fiscal 2016 was $230.06M, a 50.19% increase from fiscal 2015.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for fiscal 2015 was $153.18M, a 32.68% increase from fiscal 2014.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for fiscal 2014 was $115.45M, a 28.86% increase from fiscal 2013.
  • SUCAMPO PHARMACEUTICALS, INC. revenues for fiscal 2013 was $89.59M, a 9.95% increase from fiscal 2012.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2017-09-30$61.27M
10-Q · filed 2017-11-01
$121.16M
derived: sum of 2 quarters · filed 2017-11-01
$177.44M
10-Q · filed 2017-11-01
$250.47M
derived: sum of 4 quarters · filed 2017-11-01
2017-06-30$59.90M
10-Q · filed 2017-08-02
$116.18M
10-Q · filed 2017-08-02
$189.20M
derived: sum of 3 quarters · filed 2017-08-02
$247.08M
derived: sum of 4 quarters · filed 2017-11-01
2017-03-31$56.28M
10-Q · filed 2017-05-03
$129.31M
derived: sum of 2 quarters · filed 2017-05-03
$187.18M
derived: sum of 3 quarters · filed 2017-11-01
$239.13M
derived: sum of 4 quarters · filed 2017-11-01
2016-12-31$73.02M
10-K · filed 2017-03-08
$130.90M
derived: sum of 2 quarters · filed 2017-11-01
$182.85M
derived: sum of 3 quarters · filed 2017-11-01
$230.06M
10-K · filed 2017-03-08
2016-09-30$57.87M
10-Q · filed 2017-11-01
$109.82M
derived: sum of 2 quarters · filed 2017-11-01
$157.03M
10-Q · filed 2017-11-01
$212.40M
derived: sum of 4 quarters · filed 2017-11-01
2016-06-30$51.95M
10-Q · filed 2017-08-02
$99.16M
10-Q · filed 2017-08-02
$154.53M
derived: sum of 3 quarters · filed 2017-08-02
$187.97M
derived: sum of 4 quarters · filed 2017-08-02
2016-03-31$47.21M
10-Q · filed 2017-05-03
$102.58M
derived: sum of 2 quarters · filed 2017-05-03
$136.02M
derived: sum of 3 quarters · filed 2017-05-03
$170.91M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31$55.37M
10-K · filed 2017-03-08
$88.82M
derived: sum of 2 quarters · filed 2017-03-08
$123.70M
derived: sum of 3 quarters · filed 2017-03-08
$153.18M
10-K · filed 2017-03-08
2015-09-30$33.45M
10-K · filed 2017-03-08
$68.33M
derived: sum of 2 quarters · filed 2017-03-08
$97.81M
10-Q · filed 2016-11-09
$135.57M
derived: sum of 4 quarters · filed 2017-03-08
2015-06-30$34.88M
10-K · filed 2017-03-08
$64.36M
10-Q · filed 2016-08-03
$102.12M
derived: sum of 3 quarters · filed 2017-03-08
$133.58M
derived: sum of 4 quarters · filed 2017-03-08
2015-03-31$29.48M
10-K · filed 2017-03-08
$67.24M
derived: sum of 2 quarters · filed 2017-03-08
$98.70M
derived: sum of 3 quarters · filed 2017-03-08
$122.77M
derived: sum of 4 quarters · filed 2017-03-08
2014-12-31$37.76M
10-K/A · filed 2016-03-16
$69.22M
derived: sum of 2 quarters · filed 2016-03-16
$93.29M
derived: sum of 3 quarters · filed 2016-03-16
$115.45M
10-K · filed 2017-03-08
2014-09-30$31.46M
10-K/A · filed 2016-03-16
$55.53M
derived: sum of 2 quarters · filed 2016-03-16
$77.69M
10-Q · filed 2015-11-04
$102.18M
derived: sum of 4 quarters · filed 2016-03-16
2014-06-30$24.07M
10-K/A · filed 2016-03-16
$46.23M
10-Q · filed 2015-08-05
$70.72M
derived: sum of 3 quarters · filed 2016-03-16
$91.88M
derived: sum of 4 quarters · filed 2016-03-16
2014-03-31$22.16M
10-K/A · filed 2016-03-16
$46.65M
derived: sum of 2 quarters · filed 2016-03-16
$67.81M
derived: sum of 3 quarters · filed 2016-03-16
$94.84M
derived: sum of 4 quarters · filed 2016-03-16
2013-12-31$24.49M
10-K · filed 2015-03-09
$45.65M
derived: sum of 2 quarters · filed 2015-03-09
$72.68M
derived: sum of 3 quarters · filed 2015-03-09
$89.59M
10-K/A · filed 2016-03-16
2013-09-30$21.16M
10-K · filed 2015-03-09
$48.19M
derived: sum of 2 quarters · filed 2015-03-09
$65.10M
10-Q · filed 2014-11-07
$99.97M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$27.02M
10-K · filed 2015-03-09
$43.94M
10-Q · filed 2014-08-06
$78.80M
derived: sum of 3 quarters · filed 2015-03-09
$94.30M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$16.92M
10-K · filed 2015-03-09
$51.78M
derived: sum of 2 quarters · filed 2015-03-09
$67.28M
derived: sum of 3 quarters · filed 2015-03-09
$83.96M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$34.86M
10-K · filed 2014-03-12
$50.36M
derived: sum of 2 quarters · filed 2014-03-12
$67.04M
derived: sum of 3 quarters · filed 2014-03-12
$81.49M
10-K · filed 2015-03-09
2012-09-30$15.50M
10-K · filed 2014-03-12
$32.18M
derived: sum of 2 quarters · filed 2014-03-12
$46.63M
10-Q · filed 2013-11-08
$60.84M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30$16.68M
10-K · filed 2014-03-12
$31.13M
10-Q · filed 2013-08-09
$45.34M
derived: sum of 3 quarters · filed 2014-03-12
$59.72M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31$14.45M
10-K · filed 2014-03-12
$28.66M
derived: sum of 2 quarters · filed 2014-03-12
$43.03M
derived: sum of 3 quarters · filed 2014-03-12
$57.03M
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31$14.21M
10-K · filed 2013-03-18
$28.59M
derived: sum of 2 quarters · filed 2013-03-18
$42.59M
derived: sum of 3 quarters · filed 2013-03-18
$54.76M
10-K · filed 2014-03-12
2011-09-30$14.37M
10-K · filed 2013-03-18
$28.37M
derived: sum of 2 quarters · filed 2013-03-18
$40.55M
10-Q · filed 2012-11-09
$52.90M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$14.00M
10-K · filed 2013-03-18
$26.17M
10-Q · filed 2012-08-09
$38.52M
derived: sum of 3 quarters · filed 2013-03-18
$59.43M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$12.17M
10-K · filed 2013-03-18
$24.52M
derived: sum of 2 quarters · filed 2013-03-18
$45.43M
derived: sum of 3 quarters · filed 2013-03-18
$59.21M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$12.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$33.26M
derived: sum of 2 quarters · filed 2013-03-18
$47.03M
derived: sum of 3 quarters · filed 2013-03-18
$61.87M
10-K · filed 2013-03-18
2010-09-30$20.91M
10-Q · filed 2011-11-09
$34.68M
derived: sum of 2 quarters · filed 2011-11-09
$49.52M
10-Q · filed 2011-11-09
2010-06-30$13.78M
10-Q · filed 2011-08-05
$28.61M
10-Q · filed 2011-08-05
2009-12-31$67.35M
10-K · filed 2012-03-15